What the Bendit17 microcatheter FDA clearance signals for catheter innovation

What the Bendit17 microcatheter FDA clearance signals for catheter innovation

Bendit Technologies has secured 510(k) clearance from the U.S. Food and Drug Administration for its Bendit17 steerable microcatheter, a device the company describes as the smallest steerable microcatheter available for use in neurovascular and peripheral endovascular interventions. With U.S. commercialization slated to begin in January 2026, the Israel-based medical device manufacturer is also pursuing regulatory […]

What Neurizon’s entry into the HEALEY ALS trial means for the future of NUZ-001

What Neurizon’s entry into the HEALEY ALS trial means for the future of NUZ-001

Neurizon Therapeutics Limited has received clearance from the United States Food and Drug Administration for its investigational therapy NUZ-001 to be included in the HEALEY ALS Platform Trial, a globally recognized adaptive trial framework for amyotrophic lateral sclerosis. The decision formally designates NUZ-001 as Regimen I in the platform, allowing clinical site activation and study […]